Implication of steady state concentrations of nitrite and nitrate metabolites of nitric oxide in plasma and whole blood in healthy human subjects

Clinical and Experimental Pharmacology and Physiology

Volumn 31, Issue 9, 2004, Pages 591-596

  Himeno, Mariko ^a   Ishibashi, Takaharu ^a   Nakano, Shigeru ^a   Furuya, Keisuke ^a   Yoshida, Junko ^a   Kigoshi, Toshikazu ^a   Uchida, Kenzo ^a   Nishio, Matomo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Blood; Erythrocytes; Nitrate; Nitric oxide; Nitrite; Plasma; Steady state

Indexed keywords

CREATINE; NITRATE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ERYTHROCYTE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; METABOLITE; NORMAL HUMAN; PLASMA; PROTEIN BLOOD LEVEL; STEADY STATE;

ADULT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; ERYTHROCYTES; HUMANS; KINETICS; NITRATES; NITRIC OXIDE; NITRITES; PLASMA; TIME FACTORS;

EID: 4944221721     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2004.04060.x     Document Type: Article

References (40)

1. Marin J, Rodriguez-Martinez MA. Role of vascular nitric oxide in physiological and pathological conditions. Pharmacol. Ther. 1997; 75: 111-34.
2. Vallance P, Chan N. Endothelial function and nitric oxide: Clinical relevance. Heart 2001; 85: 342-50.
3. Ishibashi T, Yoshida J, Nishio M. Evaluation of NOx in the cardiovascular system: Relationship to NO-related compounds in vivo. Jpn. J. Pharmacol. 1999; 81: 317-23.
4. Jungersten L, Edlund A, Petersson AS, Wennmalm Å. Plasma nitrate as an index of nitric oxide formation in man: Analyses of kinetics and confounding factors. Clin. Physiol. 1996; 16: 369-79.
5. Yang BK, Vivas EX, Reiter CD, Gladwin MT. Methodologies for the sensitive and specific measurement of S-nitrosothiols, iron-nitrosyls, and nitrite in biological samples. Free Radic. Res. 2003; 37: 1-10.
6. Ellis G, Adatia I, Yazdanpanah M, Makela SK. Nitrite and nitrate analyses: A clinical biochemistry perspective. Clin. Biochem. 1998; 31: 195-220.
7. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand. J. Clin. Lab. Invest. 1996; 56: 577-81.
8. van Vliet JJ, Vaessen HA, van den Burg G, Schothorst RC. Twenty-four-hour duplicate diet study 1994: Nitrate and nitrite. Method development and intake per person per day. Cancer Lett. 1997; 114: 305-7.
9. Evans TG, Rasmussen K, Wiebke G, Hibbs JBJ. Nitric oxide synthesis in patients with advanced HIV infection. Clin. Exp. Immunol. 1994; 97: 83-6.
10. Wang J, Brown MA, Tam SH, Chan MC, Whitworth JA. Effects of diet on measurement of nitric oxide metabolites. Clin. Exp. Pharmacol. Physiol. 1997; 24: 418-20.
11. Benthin G, Bjorkhem I, Breuer O, Sakinis A, Wennmalm Å. Transformation of subcutaneous nitric oxide into nitrate in the rat. Biochem. J. 1997; 323: 853-8.
12. Rhodes P, Leone AM, Francis PL et al. The L-arginine : nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem. Biophys. Res. Commun. 1995; 209: 590-6.
13. Westfelt UN, Benthin G, Lundin S, Stenqvist O, Wennmalm Å. Conversion of inhaled nitric oxide to nitrate in man. Br. J. Pharmacol. 1995; 114: 1621-4.
14. Gunn RB, Wieth JO, Tosteson DC. Some effects of low pH on chloride exchange in human red blood cells. J. Gen. Physiol. 1975; 65: 731-49.
15. Herken H, Uz E, Ozyurt H, Akyol O. Red blood cell nitric oxide levels in patients with schizophrenia. Schizophr. Res. 2001; 52: 289-90.
16. Recchia FA, Vogel TR, Hintze TH. NO metabolites accumulate in erythrocytes in proportion to carbon dioxide and bicarbonate concentration. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H852-6.
17. Himeno M, Ishibashi T, Nakano S et al. A practical procedure for achieving a steady state of NOx concentration in plasma: With special reference to the NOx content of Japanese daily food. Tohoku J. Exp. Med. 2003; 199: 95-110.
18. Ishibashi T, Kubota K, Himeno M et al. Respiratory alkalosis does not alter NOx concentrations in human plasma and erythrocytes. Am. J. Physiol. Heart Circ. Physiol. 2001; 281: H2757-61.
19. Hinderling PH. Red blood cells: A neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacol. Rev. 1997; 49: 279-95.
20. 15N-labeled nitrate in humans: Effect of diet supplementation with ascorbic acid. Cancer Res. 1983; 43: 1921-5.
21. Ishibashi T, Himeno M, Imaizumi N et al. NOx contamination in laboratory ware and effect of countermeasures. Nitric Oxide 2000; 4: 516-25.
22. Ellen G, Schuller PL, Bruijns E, Froeling PG, Baadenhuijsen HU. Volatile N-Nitrosamines, Nitrate and Nitrite in Urine and Saliva of Healthy Volunteers After Administration of Large Amounts of Nitrate. IARC Science Publishers, Lyon. 1982.
23. Sakinis A, Wennmalm Å. Estimation of total rate of formation of nitric oxide in the rat. Biochem. J. 1998; 330: 527-32.
24. 18oxygen inhalation method for determination of total body formation of nitric oxide in humans. Clin. Physiol. 1999; 19: 504-9.
25. 15N]citrulline labeling. Proc. Natl Acad. Sci. USA 1996; 93: 11 460-5.
26. Mochizuki S, Toyota E, Hiramatsu O et al. Effect of dietary control on plasma nitrate level and estimation of basal systemic nitric oxide production rate in humans. Heart Vessels 2000; 15: 274-9.
27. Garcia-Romeu F, Cossins AR, Motais R. Cell volume regulation by trout erythrocytes: Characteristics of the transport systems activated by hypotonic swelling. J. Physiol. 1991; 440: 547-67.
28. Motais R, Guizouarn H, Garcia-Romeu F. Red cell volume regulation: The pivotal role of ionic strength in controlling swelling-dependent transport systems. Biochim. Biophys. Acta 1991; 1075: 169-80.
29. Hori T, Matsubara T, Ishibashi T et al. Decrease of nitric oxide end-products during coronary circulation reflects elevated basal coronary artery tone in patients with vasospastic angina. Jpn. Heart J. 2000; 41: 583-95.
30. Hori T, Matsubara T, Ishibashi T et al. Significance of asymmetric dimethylarginine (ADMA) concentrations during coronary circulation in patients with vasospastic angina. Circ. J. 2003; 67: 305-11.
31. - difference in human coronary circulation with severe atherosclerotic stenosis. Life Sci. 2000; 66: 173-84.
32. Ishibashi T, Himeno T, Kubota K et al. Decrease in plasma NOx concentration by isosorbide dinitrate, an organic nitrate ester. J. Cardiovasc. Pharmacol. 2003; 41: 40-8.
33. Wennmalm Å, Benthin G, Petersson AS. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br. J. Pharmacol. 1992; 106: 507-8.
34. Wennmalm Å. Metabolism and excretion of nitric oxide in man: Basal studies and clinical applications. Agents Actions Suppl. 1995; 45: 129-38.
35. Green LC, Ruiz DL, Wagner DA et al. Nitrate biosynthesis in man. Proc. Natl Acad. Sci. USA 1981; 78: 7764-8.
36. Mackenzie IM, Ekangaki A, Young JD, Garrard CS. Effect of renal function on serum nitrogen oxide concentrations. Clin. Chem. 1996; 42: 440-4.
37. Lauer T, Preik M, Rassaf T et al. Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proc. Natl Acad. Sci. USA 2001; 98: 12 814-19.
38. Xu B, Xiao-hong L, Lin G, Queen L, Ferro A. Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. Br. J. Pharmacol. 2002; 136: 375-82.
39. Maejima K, Himeno M, Ishibashi T et al. Paradoxical decrease in plasma NOx by L-arginine load in diabetic and non-diabetic subjects. Clin. Exp. Hypertens. 2002; 24: 155-67.
40. - transport via anion exchanger in erythrocytes: Inertness of DIDS in whole blood. J. Pharmacol. Sci. 2003; 93: 505-8.